Advanced Search

Amendment Of The Biocides Act Old Active Ingredient Regulation For The Third Time

Original Language Title: Änderung der BiozidG-Altwirkstoffverordnung zum dritten Mal

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.

199. Ordinance of the Federal Minister for Agriculture, Forestry, Environment and Water Management, with which the Biocides Ordinance is amended for the third time

On the basis of § 4 (2) of the Biocidal Products Act - Biocide G, BGBl. No 105/2000, in the version of the Federal Law BGBl. I n ° 151/2004 and the Federal Ministries of the Federal Ministries of Law 2009, BGBl. I No 3/2009, shall be ordered:

The Biocides-G-Old-Life-Ingredient Ordinance, BGBl. II No 353/2008, as amended by the BGBl Regulation. II No 94/2011, shall be amended as follows:

1. § 2 (5) reads:

" (5) If an authorisation is granted for a biocidal product subject to the authorisation requirement laid down in paragraphs 1 and 2 above and for the authorisation of the biocidal product,

1.

a communication pursuant to paragraph 1 has been received, or

2.

an application for admission pursuant to § § 11 (1), (13) or 15 Biocides (Biocides) has been submitted,

, the admissibility of the placing on the market of the biocidal product concerned shall end with the refusal to grant the notification in accordance with paragraph 1, or because the application is withdrawn, rejected or dismissed. final cessation of the proceedings or with the entry of the legal force of rejection or dismissal of the application. If, together with such a decision, a period of sale within the meaning of Article 17 (6) of the Biocidal Products Act is also established for the biocidal product concerned, the placing on the market of the biocidal product concerned shall remain until the end of this period. Withdrawal period allowed. "

2. § 4 (5) reads:

" (5) If a registration for a low-risk biocidal product is subject to the registration requirement set out in paragraphs 1 and 2 above and for which:

1.

a communication pursuant to paragraph 1 has been received or for which:

2.

an application for registration pursuant to § § 11 para. 2, 14 or 15 Biocide-G has been filed,

where the notification referred to in paragraph 1 has not been supplemented, or because the application is withdrawn, rejected or dismissed, the admissibility of placing on the market of the biocidal product concerned shall end with a low Risk potential with the final cessation of the proceedings or with the entry of the legal force of rejection or dismissal of the application. If, together with such a decision, a period of sale within the meaning of Article 17 (6) of the Biocidal Products Act is also established for the biocidal product concerned with a low risk potential, the placing on the market of the biocidal product concerned shall remain unchanged. with low-risk potential, however, shall be allowed until the end of this period of sale. "

3. In § 8 (2) the word "or" at the end of Z 8, replaced by a dash; at the end of Z 9, an addition shall be added. The following Z 10 to 12 shall be inserted:

" 10.

Commission Decision of 1 July 2011 concerning the non-inclusion of certain active substances in Annex I, IA or IB to Directive 98 /8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (2011/391/EU), OJ L 136, 31.5.2011, p. No. OJ L 175, 02.07.2011 p. 28,

11.

Commission Decision of 9 February 2012 concerning the non-inclusion of flufenoxuron in Annex I, IA or IB to Directive 98 /8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market for product type 18 (2012/77/EU), OJ No. OJ L 38 of 11.02.2012 p. 47, or

12.

Commission Decision of 9 February 2012 concerning the non-inclusion of certain active substances in Annex I, IA or IB to Directive 98 /8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (2012/78/EU), OJ L 136, 31.5.2012, p. No. OJ L 38 of 11.02.2012 p. 48 "

4. In § 9, the word "and" at the end of Z 36, replaced by a dash; at the end of Z 37, a dash shall be added. The following Z 38 to 51 shall be inserted:

" 38.

Directive 2011 /10/EU amending Directive 98 /8/EC of the European Parliament and of the Council for the inclusion of the active substance bifenthrin in Annex I to product type 8, OJ L 327, 28.11.2011, p. No. OJ L 34 of 09.02.2011 p. 4,

39.

Directive 2011 /11/EU amending Directive 98 /8/EC of the European Parliament and of the Council with a view to the inclusion of the active substance (Z, E) -tetradeca-9, 12-dienylactetat in Annex I under product type 19, OJ L 206, 22.7.2011, p. No. OJ L 34, 09.02.2011 p. 45,

40.

Directive 2011 /12/EU amending Directive 98 /8/EC of the European Parliament and of the Council to include fenoxycarb as an active substance in Annex I to product type 8, OJ L 206, 22.7.2011, p. No. OJ L 34, 09.02.2011 p. 49,

41.

Directive 2011 /13/EU amending Directive 98 /8/EC of the European Parliament and of the Council to include nonanoic acid as active substance in Annex I to product type 19, OJ L 206, 22.7.2011, p. No. OJ L 34, 09.02.2011 p. 52,

42.

Directive 2011 /66/EU amending Directive 98 /8/EC of the European Parliament and of the Council for the inclusion of the active substance 4,5-dichloro-2-octyl-2H-isothiazol-3-one in Annex I under product type 8, OJ L 136, 31.5.2011, p. No. OJ L 175, 02.07.2011 p. 10,

43.

Directive 2011 /67/EU amending Directive 98 /8/EC of the European Parliament and of the Council to include abamectin as an active substance in Annex I to product type 18, OJ L 327, 30.11.2011, p. No. OJ L 175, 02.07.2011 p. 13,

44.

Directive 2011 /69/EU amending Directive 98 /8/EC of the European Parliament and of the Council for the inclusion of the active substance imidacloprid in Annex I to product type 18, OJ L 327, 28.11.2011, p. No. OJ L 175, 02.07.2011 p. 24,

45.

Directive 2011 /71/EU amending Directive 98 /8/EC of the European Parliament and of the Council to include creosote as active substance in Annex I to product type 8, OJ L 327, 30.11.2011, p. No. OJ L 195, 27.07.2011 p. 46,

46.

Directive 2011 /78/EU amending Directive 98 /8/EC of the European Parliament and of the Council with a view to the inclusion of the active substance Bacillus thuringiensis subsp. israelensis in Annex I under product type 18, OJ L 327, 30.4.2002, p No. OJ L 243, 21.09.2011 p. 7,

47.

Directive 2011 /79/EU amending Directive 98 /8/EC of the European Parliament and of the Council for the inclusion of the active substance fipronil in Annex I to product type 18, OJ L 327, 28.11.2011, p. No. OJ L 243, 21.09.2011 p. 10,

48.

Directive 2011 /80/EU amending Directive 98 /8/EC of the European Parliament and of the Council to include lambda-Cyhalothrin as an active substance in Annex I to product type 18, OJ L 327, 28.11.2011, p. No. OJ L 243, 21.09.2011 p. 13 and

49.

Directive 2011 /81/EU amending Directive 98 /8/EC of the European Parliament and of the Council with a view to the inclusion of the active substance deltamethrin in Annex I of product type 18, OJ L 327, 30.11.2011, p. No. OJ L 243, 21.09.2011 p. 16,

50.

Directive 2012/2/EU amending Directive 98 /8/EC of the European Parliament and of the Council to include copper (II) oxide, copper (II) hydroxide and basic copper carbonate as active substances in Annex I to product type 8, OJ L 206, 22.7.1998, p. No. OJ L 37 of 10.02.2012 p. 60 and

51.

Directive 2012/3/EU amending Directive 98 /8/EC of the European Parliament and of the Council for the inclusion of the active substance bendiocarb in Annex I to product type 18, OJ L 327, 28.12.1998, p. No. OJ L 37 of 10.02.2012 p. 65 "

(5) The Annex is: (see Annexes)

Berlakovich